Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan Gerstoft

Showing results (281-290 of 306) with videos related to

Pageof 31
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 3, 2020
Impact of Human Immunodeficiency Virus-Related Gut Microbiota Alterations on Metabolic Comorbid ConditionsMarco Gelpi, Beate Vestad, Simen Hyll Hansen, et al.
European Heart Journal|July 9, 2021
HIV infection is associated with thoracic and abdominal aortic aneurysms: a prospective matched cohort studyJulie Høgh, Michael Huy Cuong Pham, Andreas Dehlbæk Knudsen, et al.
AIDS (London, England)|November 26, 2019
Impact of early antiretroviral treatment on sexual behaviour: a randomised comparisonFiona C Lampe, Alison J Rodger, William Burman, et al.
Scandinavian Journal of Gastroenterology|November 1, 2016
Vertical transmission of hepatitis B virus during pregnancy and delivery in DenmarkNina Weis, Susan Cowan, Sofie Hallager, et al.
Open Forum Infectious Diseases|December 13, 2016
Early Antiretroviral Therapy at High CD4 Counts Does Not Improve Arterial Elasticity: A Substudy of the Strategic Timing of AntiRetroviral Treatment (START) TrialJason V Baker, Katherine Huppler Hullsiek, Nicole Wyman Engen, et al.
BMC Infectious Diseases|September 3, 2025
No changes in weight, body composition or metabolic parameters after the switch to dolutegravir and lamivudine compared to continued treatment with dolutegravir, abacavir and lamivudine for virologically suppressed HIV infection (The AVERTAS trial)Karen Brorup Heje, Magnus Søltoft Lindhardt, Alessandra Meddis, et al.
Cell Reports|March 2, 2022
Epitope length variants balance protective immune responses and viral escape in HIV-1 infectionPhillip Pymm, Stefan Tenzer, Edmund Wee, et al.
Nature Immunology|May 5, 2009
Antigen processing influences HIV-specific cytotoxic T lymphocyte immunodominanceStefan Tenzer, Edmund Wee, Anne Burgevin, et al.
The Lancet Regional Health. Europe|July 22, 2024
All-cause and AIDS-related mortality among people with HIV across Europe from 2001 to 2020: impact of antiretroviral therapy, tuberculosis and regional differences in a multicentre cohort studyChristian Kraef, Erich Tusch, Sabine Singh, et al.
Journal of Internal Medicine|November 29, 2021
Humoral response to two doses of BNT162b2 vaccination in people with HIVLine Dam Heftdal, Andreas Dehlbaek Knudsen, Sebastian Rask Hamm, et al.
Pageof 31

Showing results (281-290 of 306) with videos related to

Sort By:
Pageof 31
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 3, 2020
Impact of Human Immunodeficiency Virus-Related Gut Microbiota Alterations on Metabolic Comorbid ConditionsMarco Gelpi, Beate Vestad, Simen Hyll Hansen, et al.
European Heart Journal|July 9, 2021
HIV infection is associated with thoracic and abdominal aortic aneurysms: a prospective matched cohort studyJulie Høgh, Michael Huy Cuong Pham, Andreas Dehlbæk Knudsen, et al.
AIDS (London, England)|November 26, 2019
Impact of early antiretroviral treatment on sexual behaviour: a randomised comparisonFiona C Lampe, Alison J Rodger, William Burman, et al.
Scandinavian Journal of Gastroenterology|November 1, 2016
Vertical transmission of hepatitis B virus during pregnancy and delivery in DenmarkNina Weis, Susan Cowan, Sofie Hallager, et al.
Open Forum Infectious Diseases|December 13, 2016
Early Antiretroviral Therapy at High CD4 Counts Does Not Improve Arterial Elasticity: A Substudy of the Strategic Timing of AntiRetroviral Treatment (START) TrialJason V Baker, Katherine Huppler Hullsiek, Nicole Wyman Engen, et al.
BMC Infectious Diseases|September 3, 2025
No changes in weight, body composition or metabolic parameters after the switch to dolutegravir and lamivudine compared to continued treatment with dolutegravir, abacavir and lamivudine for virologically suppressed HIV infection (The AVERTAS trial)Karen Brorup Heje, Magnus Søltoft Lindhardt, Alessandra Meddis, et al.
Cell Reports|March 2, 2022
Epitope length variants balance protective immune responses and viral escape in HIV-1 infectionPhillip Pymm, Stefan Tenzer, Edmund Wee, et al.
Nature Immunology|May 5, 2009
Antigen processing influences HIV-specific cytotoxic T lymphocyte immunodominanceStefan Tenzer, Edmund Wee, Anne Burgevin, et al.
The Lancet Regional Health. Europe|July 22, 2024
All-cause and AIDS-related mortality among people with HIV across Europe from 2001 to 2020: impact of antiretroviral therapy, tuberculosis and regional differences in a multicentre cohort studyChristian Kraef, Erich Tusch, Sabine Singh, et al.
Journal of Internal Medicine|November 29, 2021
Humoral response to two doses of BNT162b2 vaccination in people with HIVLine Dam Heftdal, Andreas Dehlbaek Knudsen, Sebastian Rask Hamm, et al.
Pageof 31